CN Stock MarketDetailed Quotes

600535 Tasly Pharmaceutical Group

Watchlist
  • 13.98
  • -0.08-0.57%
Market Closed Jan 8 15:00 CST
20.89BMarket Cap23.69P/E (TTM)

Tasly Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tasly Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 24, 20242024/Q22.323B / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--
--2020/Q42.185B / 1.519B--
DatePeriodRevenue/EstimateEarnings Call
Aug 24, 20242024/Q22.323B / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--
--2020/Q42.185B / 1.519B--

Unlock Free Earnings Estimates

Tasly Pharmaceutical Group Earnings Reports

  • Tianshili\'s announcement on the company\'s main operating data for the first three quarters of 2024

    Oct 25, 2024 12:00 ET

  • Tasly 2024 Third Quarter Report

    Oct 25, 2024 12:00 ET

  • Tasly Pharmaceutical Group 2024 Semi-Annual Report

    Aug 23, 2024 12:00 ET

  • Summary of Tasly Pharmaceutical Group's 2024 semi-annual report

    Aug 23, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 8, 2025

    Strong Buy

    • Strong Buy

      68.42%

    • Buy

      31.58%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Shuanghuanglian
    Shuanghuanglian
    Intraday+0.53%
    ShangHai Stock Connect
    ShangHai Stock Connect
    Intraday+0.24%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday+0.04%